Perseus Proteomics Balance Sheet Health
Financial Health criteria checks 6/6
Perseus Proteomics has a total shareholder equity of ¥1.8B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥2.2B and ¥353.0M respectively.
Key information
0%
Debt to equity ratio
JP¥0
Debt
| Interest coverage ratio | n/a |
| Cash | JP¥2.09b |
| Equity | JP¥1.84b |
| Total liabilities | JP¥353.00m |
| Total assets | JP¥2.19b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4882's short term assets (¥2.1B) exceed its short term liabilities (¥136.0M).
Long Term Liabilities: 4882's short term assets (¥2.1B) exceed its long term liabilities (¥217.0M).
Debt to Equity History and Analysis
Debt Level: 4882 is debt free.
Reducing Debt: 4882 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4882 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 4882 has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 19.6% each year.